Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)
NCT00493129
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Systemic Mastocytosis
Interventions
DRUG:
Ontak (Denileukin Diftitox)
Sponsor
M.D. Anderson Cancer Center